Critical Governance & Disclosure
Board, Voting & Shareholder Rights
Capital Structure & Financial Risk
Disclosure & Communications
Current report
2026-11-12
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2026-11-12
Preliminary Proxy Soliciting materials
2026-10-28
Statement of changes in beneficial ownership of securities
2026-09-24
Statement of changes in beneficial ownership of securities
2026-09-24
No Insider Transactions found for Skye Bioscience, Inc.
TOP
View Filings